The present application relates to novel bisaryl-bonded 5-aryl-1,2,4-triazolone derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of disorders, and to the use thereof for production of medicaments for treatment and/or prevention of disorders, especially for treatment and/or prevention of cardiovascular diseases.